Related Experiment Videos
[Routine vaccination in childhood]
1Pädiatrische Universitätsklinik, Basler Kinderspital.
Insights
Switzerland updated its vaccination schedule in 1996, introducing new pertussis vaccines and combination vaccines. The schedule now includes additional doses and recommends a second Measles, Mumps, and Rubella (MMR) vaccine dose for enhanced protection.
Area of Science:
- Public Health
- Immunology
- Pediatrics
Context:
- Revisions to the Swiss national immunization program implemented in spring 1996.
- Introduction of acellular pertussis vaccines to minimize adverse effects.
- Integration of combination vaccines for Diphtheria, Tetanus, Pertussis (DTP), and Haemophilus influenzae type b (Hib).
Purpose:
- To detail significant modifications in the Swiss vaccination schedule.
- To enhance vaccine efficacy and safety through updated vaccine types and dosing.
- To improve individual and community protection against vaccine-preventable diseases.
Summary:
- The updated schedule incorporates acellular pertussis vaccines, allowing for additional doses at ages 2 and 4-7 years.
- Combination vaccines for DTP and Hib are now considered, simplifying administration.
- A second dose of Measles, Mumps, and Rubella (MMR) vaccine is recommended between 4-7 years to bolster immunity.
Impact:
- Expected increase in vaccination coverage and individual immune protection.
- Reduced incidence of side effects associated with pertussis vaccination.
- Anticipation of a future recommendation for adolescent Hepatitis B vaccination in 1998.
Abstract:
Some major modifications of the recommended Swiss vaccination schedule have been introduced in spring 1996: 1. The vaccination against pertussis using the new acellular vaccines, which cause fewer side-effects. This allows the administration of a fourth and a fifth dose at the age of 2 and 4-7 years, respectively. 2. The consideration of combination vaccines, which contain the vaccinations against diphtheria, tetanus and pertussis as well as the vaccine against invasive diseases caused by Haemophilus influenzae type b. 3. In order to increase the individual vaccination protection, a second dose of MMR vaccine is recommended, preferably at the age of 4-7 years. A general recommendation for hepatitis B vaccination during adolescence may be expected in 1998.